tradingkey.logo

Avalon Globocare Corp

ALBT
0.635USD
+0.031+5.22%
終値 02/06, 16:00ET15分遅れの株価
2.60M時価総額
損失額直近12ヶ月PER

Avalon Globocare Corp

0.635
+0.031+5.22%

詳細情報 Avalon Globocare Corp 企業名

Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.

Avalon Globocare Corpの企業情報

企業コードALBT
会社名Avalon Globocare Corp
上場日Feb 22, 2016
最高経営責任者「CEO」Jin (David)
従業員数5
証券種類Ordinary Share
決算期末Feb 22
本社所在地4400 Route 9
都市FREEHOLD
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号07728
電話番号17327804400
ウェブサイトhttps://www.avalon-globocare.com/
企業コードALBT
上場日Feb 22, 2016
最高経営責任者「CEO」Jin (David)

Avalon Globocare Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Wenzhao (Daniel) Lu
Mr. Wenzhao (Daniel) Lu
Chairman of the Board of Directors
Chairman of the Board of Directors
238.93K
--
Dr. David Jin, M.D., Ph.D.
Dr. David Jin, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.00K
--
Ms. Meng Li
Ms. Meng Li
Chief Operating Officer, Secretary
Chief Operating Officer, Secretary
34.33K
--
Mr. Steven Andrew Sanders, J.D.
Mr. Steven Andrew Sanders, J.D.
Independent Director
Independent Director
--
--
Mr. Wilbert J. (Billy) Tauzin, II
Mr. Wilbert J. (Billy) Tauzin, II
Director
Director
--
--
Mr. William B. Stilley, III
Mr. William B. Stilley, III
Independent Director
Independent Director
--
--
Dr. The Hon. Tevi Troy, Ph.D.
Dr. The Hon. Tevi Troy, Ph.D.
Independent Director
Independent Director
--
--
Ms. Luisa Ingargiola
Ms. Luisa Ingargiola
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Lourdes Felix
Ms. Lourdes Felix
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Wenzhao (Daniel) Lu
Mr. Wenzhao (Daniel) Lu
Chairman of the Board of Directors
Chairman of the Board of Directors
238.93K
--
Dr. David Jin, M.D., Ph.D.
Dr. David Jin, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.00K
--
Ms. Meng Li
Ms. Meng Li
Chief Operating Officer, Secretary
Chief Operating Officer, Secretary
34.33K
--
Mr. Steven Andrew Sanders, J.D.
Mr. Steven Andrew Sanders, J.D.
Independent Director
Independent Director
--
--
Mr. Wilbert J. (Billy) Tauzin, II
Mr. Wilbert J. (Billy) Tauzin, II
Director
Director
--
--
Mr. William B. Stilley, III
Mr. William B. Stilley, III
Independent Director
Independent Director
--
--

収益内訳

会社から関連データがまだ開示されていません。
会社から関連データがまだ開示されていません。
事業別
地域別
会社から関連データがまだ開示されていません。

株主

更新時刻: Sun, Jan 18
更新時刻: Sun, Jan 18
株主統計
種類
株主統計
株主統計
比率
Lu (Wenzhao)
5.62%
Jin (David)
2.42%
Li (Meng)
0.81%
The Vanguard Group, Inc.
0.60%
UBS Financial Services, Inc.
0.57%
他の
89.98%
株主統計
株主統計
比率
Lu (Wenzhao)
5.62%
Jin (David)
2.42%
Li (Meng)
0.81%
The Vanguard Group, Inc.
0.60%
UBS Financial Services, Inc.
0.57%
他の
89.98%
種類
株主統計
比率
Individual Investor
8.87%
Investment Advisor
1.61%
Investment Advisor/Hedge Fund
0.52%
Hedge Fund
0.01%
他の
88.99%

機関投資家保有株

更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
29
48.23K
1.25%
--
2025Q3
31
48.23K
1.39%
+17.57K
2025Q2
33
19.75K
2.15%
+2.84K
2025Q1
33
16.91K
2.05%
-16.99K
2024Q4
35
16.66K
2.06%
-67.00
2024Q3
33
16.73K
1.75%
-236.00
2024Q2
33
16.96K
1.41%
+10.31K
2024Q1
31
6.65K
1.69%
-5.84K
2023Q4
32
10.45K
1.58%
+1.42K
2023Q3
39
9.06K
1.97%
+456.00
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Lu (Wenzhao)
238.93K
5.62%
--
--
Oct 31, 2025
Jin (David)
103.00K
2.42%
--
--
Oct 31, 2025
Li (Meng)
34.33K
0.81%
--
--
Oct 31, 2025
The Vanguard Group, Inc.
25.38K
0.6%
+23.80K
+1505.50%
Sep 30, 2025
UBS Financial Services, Inc.
42.00
0%
-4.16K
-99.00%
Sep 30, 2025
Geode Capital Management, L.L.C.
22.07K
0.52%
+12.74K
+136.48%
Sep 30, 2025
Tauzin (Wilbert J II)
1.04K
0.02%
--
--
Oct 31, 2025
Tower Research Capital LLC
453.00
0.01%
+212.00
+87.97%
Sep 30, 2025
Citi Investment Research (US)
131.00
0%
-820.00
-86.23%
Sep 30, 2025
詳細を見る

関連ETF

銘柄名
比率
データなし

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
配当落ち日
種類
比率
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Jan 04, 2023
Merger
10→1
Jan 04, 2023
Merger
10→1
日付
配当落ち日
種類
比率
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Jan 04, 2023
Merger
10→1
Jan 04, 2023
Merger
10→1
Jan 04, 2023
Merger
10→1
Jan 04, 2023
Merger
10→1
KeyAI